Nicorette Lozenge
Originaltext auf Französisch.
In Kanada zugelassenes natürliches Gesundheitsprodukt
Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.
Zusammensetzung
| Arzneilicher Inhaltsstoff und Quelle | Je Dosiseinheit laut Quelle |
|---|---|
| Résinate de nicotine | 2 mg |
Nicht arzneiliche Inhaltsstoffe
Sucralose, Acésulfame-K, Saveur de Fruits, D-Mannitol, Stéarate de magnésium, Saveur de menthe, Hypromellose, Carbonate de sodium, Eau purifiée, Poly(sorbate) 80, Cellulose microcristalline, Gomme de xanthane, Pigments nacrés à base de mica, Dioxyde de titane, gomme acacia
In Kanada empfohlene Dosen
| Bevölkerungsgruppe | Alter | Menge pro Einnahme | Häufigkeit |
|---|---|---|---|
| Adultes | Non précisée | 1 Pastille | 15 Tous les jours |
In Kanada zugelassene Verwendungen
Nicorette Lozenge is a medicine that can help you stop smoking by reducing withdrawal symptoms and nicotine cravings. Nicorette Lozenge is a form of Nicotine Replacement Therapy (NRT) that can help double your chances of quitting successfully. Nicorette Lozenge provides a lower level of nicotine to your blood than cigarettes and allows you to slowly decrease your body's need for nicotine. It works as a temporary aid to help you quit smoking by reducing nicotine withdrawal symptoms such as irritability, frustration, anxiety, difficulty in concentration and restlessness. Without these powerful urges for the cigarettes you "need", getting rid of the "habit" cigarettes becomes much easier. The good news is that Nicorette Lozenge contains no tar or carbon monoxide, and therefore doesn't present the same medical risks as cigarettes. Nicorette Lozenge can be used to quit immediately or to quit gradually by reducing the number of cigarettes you smoke each day before making a quit attempt. Although smoking cessation is preferable, it can also be used in cases in which you temporarily refrain from smoking, for example, in smoke-free areas or in other situations when you wish to avoid smoking. Combination Nicotine Replacement Therapy: patch + as needed lozenge versus the nicotine patch or lozenge alone is: clinically proven to increase your chances of quitting; a clinically proven approach to increase your chances of quitting. If you have relapsed or experience tough/intense cravings or failed with lozenge alone, you can use Nicorette Lozenge with the patch at the same time to increase your chances of quit success. Now you can have the combined support of Nicoderm patch and Nicorette as needed lozenge products together, for a successful quit. Tackle cravings: Nicoderm patch for slow release constant support and Nicorette as needed lozenge for an extra quick fix/dose when you really need to fight back the cravings/when something triggers intense cravings. Combination therapy is 18%/1.18x more effective than using one Nicotine Replacement Therapy product alone. Use Nicoderm patch + Nicorette Lozenge together to increase your chance of quitting. Fast nicotine relief to help you quit. It delivers nicotine to your body, temporarily relieving craving and nicotine withdrawal symptoms when you quit smoking. Use Nicorette Lozenge 2 mg if you smoke 25 cigarettes or less a day. If you smoke more than 25 cigarette a day, use NICORETTE 4 mg Lozenge. Unlike cigarette, NICORETTE Lozenge delivers a lower, steady level of nicotine to your blood. When used as directed, NICORETTE Lozenge help you regulate, control, and gradually reduce your body's craving for nicotine.
Originaltext auf Englisch.
Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.
Warnhinweise in Kanada
Contra-Indications : Do not use if you are pregnant or breast feeding, unless you have consulted with a doctor or pharmacist before using this product; under 18 years of age; an occasional or non-smoker or are allergic to nicotine or to any of the non-medicinal ingredients in the product.
Originaltext auf Englisch.
Produktdaten
- Andere Namen
- Nova 2 mg
- Inhaber
- Kenvue Canada Inc.
- NPN oder DIN-HM
- 80053099
- Status
- Aktive Lizenz
- Lizenzdatum
- 14. August 2014
- Überarbeitungsdatum
- 15. September 2026
- Form
- Pastille
- Verabreichungsweg
- Buccale
- Art des Antrags
- Non traditionnelle
Quelle
Amtlicher Health-Canada-Eintrag, Zulassung 80053099
Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Originaltext auf Englisch.
Originaltext auf Französisch.
Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.
Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).
Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.
Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.